• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
MS Money Moves

MS Money Moves

Striving to raise financial literacy amongst today’s youth and providing top tier equity analysis

  • Home
  • Articles
  • News
  • About us
  • Performance Record
  • Become a contributor
  • Contact

Swing Trades

CPRX Swing Move For November 2018

November 9, 2018 by Sultan Leave a Comment

Investment Overview MSMM believes Catalyst Pharmaceuticals (Nasdaq: CPRX $2.88) is a good swing-move for the remainder of November of 2018. The company has a PDUFA action date on November 28th … [Read more...] about CPRX Swing Move For November 2018

Filed Under: Swing Trades Tagged With: Biomarin Pharmaceuticals, biotech stocks, BMRN, Catalyst pharmaceuticals, CMS, Congenital Myasthenic Syndromes, CPRX, LEMS, MS Picks November 2018, MuSK-MG, MuSK-Myasthenia Gravis, pharma, rare diseases

Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath

October 25, 2018 by Sultan 1 Comment

Overview Wednesday October 24th, 2018 the stock market was slashed across the board with the DOW erasing all its gains for the year and dripping red. The Nasdaq was hit with equal force. Comments from … [Read more...] about Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath

Filed Under: Market Updates, Swing Trades Tagged With: $ADMP, $NVS, $VSTM, AcelRX Pharmaceuticals, ACRX, ADMA, Adma Biologics, Admais, allergies, anaphylaxis, asthma, AVEO, binary catalyst, biotech stocks, Blood, blood cancer, bloodbath, buyout, Cancer, Cirrhosis, COPD, day trading, DSUVIA, Epipen, Fibrotic diseases, FL SL CLL cancer, Galetin Therapeutics, GALT, IG, IGs, Immunoglobulins, iNHL, invest, investing, investors, IVIG, IVIGs, money, MS Picks November 2018, Naloxone, NASH, NDA, new drug application, NHL, Novartis, Oncology, onocology, opioid, opioid epidemic, pdufa, personal finance, PI, PIDD, plasma, Sandoz, SELB, Specialty Pharmaceuticals, stock market, stocks, sufentanil, swing trading, technical analysis, TRVN, TXMD, Verastem, Verestem Oncology, zalviso

2 ACRX Insiders Sold For Massive Gains, 4 others Bought and Held-Shareholders Turn is Next

October 18, 2018 by Sultan 2 Comments

Tuesday October 16th, 2018 AcelRx Pharmaceuticals (NASDAQ: ACRX) Chief Development Officer (CDO) and Chief Engineer reported selling an aggregate of 33,567 shares at $5 per share. The month before the … [Read more...] about 2 ACRX Insiders Sold For Massive Gains, 4 others Bought and Held-Shareholders Turn is Next

Filed Under: Swing Trades Tagged With: AcelRX Pharmaceuticals, ACRX, department of defense, dod, dsuveo, DSUVIA, fda approva, opioid, opioid epidemic, pdufa, Specialty Pharmaceuticals, sufentanil, zalviso

ACRX Update-Strong Hold

October 15, 2018 by Sultan Leave a Comment

We did indeed call the swing. ACRX was trading at around$2.90 when we identified it as a good swing-trade candidate. Currently it is trading around $4.54 making for a healthy 55% gain. Where I was … [Read more...] about ACRX Update-Strong Hold

Filed Under: Swing Trades

ACRX to Spike Monday off Favorable ADCOM Vote 10-3: How to Handle It

October 13, 2018 by Sultan 11 Comments

MS Money Moves Swing thesis for AcelRX Pharma (ACRX) published last week in our "Swing Alert"article played out nicely. ACRX spiked ~70% from $2.90 to $4.92 in the last 5 trading sessions. The upward … [Read more...] about ACRX to Spike Monday off Favorable ADCOM Vote 10-3: How to Handle It

Filed Under: Swing Trades Tagged With: AcelRX Pharmaceuticals, ACRX, ADCOM, biotech, biotech stocks, DSUVIA, FDA Approval, moderate to sever pain, opioid, opioid epidemic, pain relief, pdufa, pharma, Trevena Inc, TRVN

ACRX Stay the course

October 9, 2018 by Sultan Leave a Comment

  Premarket today TRVN has dropped almost 70% off news that the FDA believes their drug Oliceridine has high abuse potential. With ACRX's ADCOM this week too I can understand the hesitation to … [Read more...] about ACRX Stay the course

Filed Under: Swing Trades

  • « Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Next Page »

Primary Sidebar

Categories

  • Market Updates
  • Equity Analysis
  • Swing Trades
  • Education
  • Interviews

MS Watchlist

MS Watchlist by TradingView
Advertisements

Sub for MS updates!

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Advertisements

Follow us!

  • Twitter
  • Facebook
  • Instagram
  • YouTube

Footer

MS Money Moves

  • Home
  • Articles
  • News
  • About us
  • Performance Record
  • Become a contributor
  • Contact

Categories

  • Market Updates
  • Equity Analysis
  • Swing Trades
  • Education
  • Interviews

Become a contributor

MS Money Moves would like to offer you the opportunity to express your unique perspective regarding publicly traded companies via our website.

All we ask is you write clearly, concisely, and have original ideas. Interested? Contact us now.

Sub for MS updates!

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Follow Us

  • Twitter
  • Facebook
  • Instagram
  • YouTube

© 2019 · MS Money Moves